Source: Hereditary Cancer in Clinical Practice. Unidade: FM
Subjects: NEOPLASIAS MAMÁRIAS (GENÉTICA), FATORES DE RISCO, GENES (ANÁLISE), DOENÇAS HEREDITÁRIAS, NEOPLASIAS OVARIANAS (GENÉTICA), MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
EWALD, Ingrid P. et al. Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome. Hereditary Cancer in Clinical Practice, v. 9, n. 1, p. (online), 2011Tradução . . Disponível em: https://doi.org/10.1186/1897-4287-9-12. Acesso em: 31 jul. 2024.APA
Ewald, I. P., Izetti, P., Vargas, F. R., Moreira, M. A. M., Moreira, A. S., Moreira-Filho, C. A., et al. (2011). Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome. Hereditary Cancer in Clinical Practice, 9( 1), (online). doi:10.1186/1897-4287-9-12NLM
Ewald IP, Izetti P, Vargas FR, Moreira MAM, Moreira AS, Moreira-Filho CA, Cunha DR, Hamaguchi S, Camey SA, Schmidt A, Caleffi M, Koehler-Santos P, Giugliani R, Ashton-Prolla P. Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome [Internet]. Hereditary Cancer in Clinical Practice. 2011 ; 9( 1): (online).[citado 2024 jul. 31 ] Available from: https://doi.org/10.1186/1897-4287-9-12Vancouver
Ewald IP, Izetti P, Vargas FR, Moreira MAM, Moreira AS, Moreira-Filho CA, Cunha DR, Hamaguchi S, Camey SA, Schmidt A, Caleffi M, Koehler-Santos P, Giugliani R, Ashton-Prolla P. Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome [Internet]. Hereditary Cancer in Clinical Practice. 2011 ; 9( 1): (online).[citado 2024 jul. 31 ] Available from: https://doi.org/10.1186/1897-4287-9-12
